Evidence map›Paper›PMID 42548548›Full record

ArticleFrontiers in physiology2026

Integrated proteomics and metabolomics reveal mechanisms of blood pressure reduction in spontaneously hypertensive rats under hypoxic conditions.

Delong Duo, Yan Wang, Guiqin Liu, Junbo Zhu, Yafeng Wang, Shanlu Bao, Xiangyang Li

Abstract read
In one paragraph

Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Delong Duo *Qinghai Provincial People's Hospital, Xining, China.
Yan Wang *Qinghai University Affiliated Hospital, Xining, China.
Guiqin LiuSchool of Pharmacy, Qinghai University, Xining, China.
Junbo ZhuSchool of Pharmacy, Qinghai University, Xining, China.
Yafeng WangQinghai Provincial People's Hospital, Xining, China.
Shanlu BaoQinghai Provincial People's Hospital, Xining, China.
Xiangyang LiSchool of Pharmacy, Qinghai University, Xining, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: High-altitude hypoxic environments markedly affect the cardiovascular system and blood pressure regulation. However, the molecular mechanisms underlying decreases in blood pressure induced by chronic hypoxia exposure in spontaneously hypertensive rats (SHRs) remain unclear. Therefore, we systematically elucidated the mechanisms by which chronic high-altitude hypoxia exposure induces adaptive molecular remodeling and subsequent decreases in blood pressure SHRs. Methods: SHRs were randomly divided into control (SHR-C, 1660 m; PaO Results and discussion: The SHR-H group exhibited pronounced reductions in systolic blood pressure, diastolic blood pressure, and mean arterial pressure compared with the SHR-C group. Proteomics analysis identified 185 differentially expressed proteins (161 upregulated and 24 downregulated). According to functional enrichment analysis, the upregulated proteins were considerably enriched in energy metabolism pathways, whereas downregulated proteins were associated with inflammatory and stress responses. Integrated protein-metabolite network analysis revealed that the tricarboxylic acid cycle was the central hub, and western blotting validated the upregulation of mitochondrial-associated proteins. Metabolomics confirmed energy metabolism reprogramming by detecting markers of enhanced fatty acid oxidation. Overall, this study provides correlative mechanistic insights into the cardiovascular effects of high-altitude hypoxic environments and proposes novel metabolic intervention strategies for hypertension, though direct functional validation is necessary to confirm the proposed mechanisms.

Indexed as

blood pressurehigh-altitude hypoxiametabolomicsproteomicsspontaneously hypertensive rats

Identifiers

PMID42548548
PMCPMC13429394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.